5-HT is associated with the dysfunction of regulating T cells in patients with allergic rhinitis

Copyright © 2022 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 243(2022) vom: 31. Okt., Seite 109101
1. Verfasser: Yang, Gui (VerfasserIn)
Weitere Verfasser: Wu, Gaohui, Yao, Wenkai, Guan, Li, Geng, Xiaorui, Liu, Jiangqi, Liu, Zhiqiang, Yang, Liteng, Huang, Qinmiao, Zeng, Xianhai, Yang, Pingchang
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't 5-HT Allergy Dendritic cells Nose Regulatory T cells Cytokines Interleukin-6 Serotonin 333DO1RDJY
Beschreibung
Zusammenfassung:Copyright © 2022 Elsevier Inc. All rights reserved.
The dysfunction of regulating T lymphocytes (Treg) is associated with the pathogenesis of many diseases. 5-hydroxytryptamine (5-HT) is capable of interacting with immune cells. The objective of the present study is to shed light on the role of 5-HT in regulating Treg activities. Blood samples were collected from patients with perennial allergic rhinitis (AR). Tregs were isolated from blood samples by magnetic cell sorting. The levels of 5-HT and other cytokines were determined by enzyme-linked immunosorbent assay. The results showed that serum 5-HT levels in patients with AR were higher than in healthy control (HC) subjects. A positive correlation was identified in the data between 5-HT concentrations and AR-related cytokine concentrations in the serum. A negative correlation was found between serum levels of 5-HT and the peripheral frequency of Treg. Exposure to 5-HT enhanced the expression of IL-6 and IL-21 in dendritic cells (DC). Co-culture of 5-HT-primed DCs with Tregs led to the conversion of Th17 cells. STAT3 blockade efficiently abolished the 5-HT-associated conversion of Th17 cells from Tregs. In summary, patients with AR exhibited higher serum concentrations of 5-HT. 5-HT-primed DCs could convert Tregs to Th17 cells
Beschreibung:Date Completed 20.09.2022
Date Revised 11.11.2022
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-7035
DOI:10.1016/j.clim.2022.109101